Skip to main content
ADVANCED SEARCH
Log in
Top
Journal of Medical Case Reports
Published in:

Open Access 12-06-2025 | Acute Lymphoblastic Leukemia | Case report

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report

Authors: Yousra Sbibih, Mohammed Bensalah, Mounia Slaoui, Abderrazak Saddari, Nabiha Trougouty, Abdelilah Berhili, Rachid Seddik

Published in: Journal of Medical Case Reports | Issue 1/2025

Login to get access

Abstract

Background

We present the case of a 6-year-old Moroccan male patient of Berber ethnic origin, diagnosed with T-cell acute lymphoblastic leukemia, who exhibited a deletion of the 5q region.

Case presentation

The patient initially presented with classic symptoms of T-cell acute lymphoblastic leukemia, including bone pain, hepatosplenomegaly, and lymphadenopathy. Laboratory tests revealed anemia, hyperleukocytosis, and a high percentage of lymphoid blasts in both the blood and bone marrow. Immunophenotyping results confirmed that these blasts were of T-cell origin. Cytogenetic analysis identified a deletion of the long arm of chromosome 5 in a subset of the patient’s cells.

Conclusion

The presence of a 5q deletion in pediatric T-cell acute lymphoblastic leukemia is an unusual finding and its prognostic significance may differ from that observed in myeloid leukemias. The implications of this cytogenetic anomaly in lymphoid malignancies remain unclear and warrant further investigation. Understanding the origins and effects of such chromosomal abnormalities in T-cell acute lymphoblastic leukemia could provide deeper insights into the disease’s pathogenesis and contribute to more tailored therapeutic strategies.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report
Authors
Yousra Sbibih
Mohammed Bensalah
Mounia Slaoui
Abderrazak Saddari
Nabiha Trougouty
Abdelilah Berhili
Rachid Seddik
Publication date
12-06-2025
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2025
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04999-x

Other articles of this Issue 1/2025

Artifacts affecting dual-energy X-ray absorptiometry and bone mineral density measurements: a case report and review of the literature

Evaluating the technetium-99 m pertechnetate flow protocol for Graves’ disease: methodological insights: a case series

Treatment for paraplegia due to severe kyphoscoliosis associated with neurofibromatosis type 1 via halo-pelvic traction: a case report

The mystery of the missing P waves: a case report

Late-onset Sheehan’s syndrome: a major diagnostic challenge—a case report

Two indirect sacs and one canal of Nuck in female inguinal hernia: a case report

ASCO 2025 Annual Meeting

Keep up to date with the latest in oncology research with our ASCO 2025 hub page, featuring official videos, breaking news, and more.

Read more

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more
SPONSORED

Masterclass webinar: Expert review of CAR T-cell therapy patient cases in R/R DLBCL or R/R FL

  • Live
  • Webinar | 29-07-2025 | 09:00 (CEST)

Professor Joy Ho leads a panel of Asia-Pacific-based experts, exchanging their practical experiences of identifying appropriate patients for CAR T-cell therapy, aspects of pre- and post-infusion management, and treatment sequencing, and sharing insights into optimizing outcomes in R/R DLBCL or R/R FL. 

This educational activity is intended for an audience of non-US, non-UK and on-label Asia Pacific healthcare professionals.

Watch it live: Tuesday 29th July, 09:00-10:30 (CEST)

Sponsored by:
  • Novartis Pharma AG
Prof. Joy Ho
Dr. Kentaro Fukushima
Prof. William Hwang
Prof. Dok Hyun Yoon
Prof. Miki Ando
Developed by: Springer Health+
Join the webinar
Webinar
Image Credits